DPP7 and colorectal carcinoma: Collectively, we recognized DPP7 as a central regulatory node governing TAM fatty acid metabolic reprogramming through CPT1A for the first time, revealing its potential as a novel therapeutic target to synergistically potentiate immunotherapy in CRC.